Matches in Wikidata for { <http://www.wikidata.org/entity/Q58160729> ?p ?o ?g. }
Showing items 1 to 62 of
62
with 100 items per page.
- Q58160729 description "article" @default.
- Q58160729 description "im Dezember 2008 veröffentlichter wissenschaftlicher Artikel" @default.
- Q58160729 description "wetenschappelijk artikel" @default.
- Q58160729 description "наукова стаття, опублікована в грудні 2008" @default.
- Q58160729 description "հոդված" @default.
- Q58160729 name "Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: A twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic scl" @default.
- Q58160729 name "Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: A twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic scl" @default.
- Q58160729 type Item @default.
- Q58160729 label "Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: A twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic scl" @default.
- Q58160729 label "Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: A twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic scl" @default.
- Q58160729 prefLabel "Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: A twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic scl" @default.
- Q58160729 prefLabel "Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: A twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic scl" @default.
- Q58160729 P1433 Q58160729-B555C81B-B960-45F4-87AC-21E573B6EE1A @default.
- Q58160729 P1476 Q58160729-FA041485-FA44-48B1-B270-DE64B335C76E @default.
- Q58160729 P2093 Q58160729-5DA687FA-9C36-4CDC-B832-6002E675207E @default.
- Q58160729 P2093 Q58160729-5E3E7769-BA22-4628-9F82-D53FC6AEE471 @default.
- Q58160729 P2093 Q58160729-5F26BD46-5600-402A-85B5-F2CF5639688A @default.
- Q58160729 P2093 Q58160729-6B016AC7-8AD7-499E-B060-73E913EA61C6 @default.
- Q58160729 P2093 Q58160729-7A03047B-0A5B-4043-AC0F-149F2C777FF9 @default.
- Q58160729 P2093 Q58160729-992511EC-4183-4C39-A6F3-9BCDE8584C0E @default.
- Q58160729 P2093 Q58160729-B92A57D9-91C5-404B-8517-437096DC1E53 @default.
- Q58160729 P2093 Q58160729-C91D7D38-C2E7-44FA-B47A-9A3124DA0DF4 @default.
- Q58160729 P2093 Q58160729-FD092723-95F1-4598-A217-975F34FB0743 @default.
- Q58160729 P2860 Q58160729-2127B57F-2713-41C4-BB70-5C55368FDC50 @default.
- Q58160729 P304 Q58160729-6FB544E7-B2EB-437A-8E91-9FDEF043A99B @default.
- Q58160729 P31 Q58160729-F614AF52-1E4C-4245-9FDE-BFCB6830FE18 @default.
- Q58160729 P356 Q58160729-0D40D601-69F2-4BAE-8BE9-C697BB89E56F @default.
- Q58160729 P433 Q58160729-557906D4-0179-4F05-9CBB-1F75E6E5E4F7 @default.
- Q58160729 P478 Q58160729-617294E4-6CB6-48C2-9574-FF60D05220CB @default.
- Q58160729 P50 Q58160729-4AB2FAB3-B2B8-47C1-816A-B9C0A2C9D7ED @default.
- Q58160729 P50 Q58160729-F64511D3-E08E-4FE3-939E-59A526857C5B @default.
- Q58160729 P577 Q58160729-2040AD32-21AA-48BA-9281-DBB8EAA3095A @default.
- Q58160729 P698 Q58160729-3429B2BA-190E-4ECF-9B37-04F98F0F1D77 @default.
- Q58160729 P921 Q58160729-9C52CC51-EC44-41D1-9FFF-C78721755897 @default.
- Q58160729 P921 Q58160729-E893A8BB-DCCF-48A5-8E29-8E8C9FDDF289 @default.
- Q58160729 P921 Q58160729-EB3FDACB-A756-47D5-A500-AA3DC5D3573B @default.
- Q58160729 P356 ART.24038 @default.
- Q58160729 P698 19035499 @default.
- Q58160729 P1433 Q23929027 @default.
- Q58160729 P1476 "Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: A twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic scl" @default.
- Q58160729 P2093 "André Roussin" @default.
- Q58160729 P2093 "France Joyal" @default.
- Q58160729 P2093 "Gilles Boire" @default.
- Q58160729 P2093 "Jean-Luc Senécal" @default.
- Q58160729 P2093 "Jean-Richard Goulet" @default.
- Q58160729 P2093 "Martial Koenig" @default.
- Q58160729 P2093 "Tamara Grodzicky" @default.
- Q58160729 P2093 "Yves Raymond" @default.
- Q58160729 P2093 "Éric Rich" @default.
- Q58160729 P2860 Q34287872 @default.
- Q58160729 P304 "3902-3912" @default.
- Q58160729 P31 Q13442814 @default.
- Q58160729 P356 "10.1002/ART.24038" @default.
- Q58160729 P433 "12" @default.
- Q58160729 P478 "58" @default.
- Q58160729 P50 Q42305888 @default.
- Q58160729 P50 Q63302292 @default.
- Q58160729 P577 "2008-12-01T00:00:00Z" @default.
- Q58160729 P698 "19035499" @default.
- Q58160729 P921 Q181600 @default.
- Q58160729 P921 Q6840468 @default.
- Q58160729 P921 Q785022 @default.